Recently, the notice of the “Guidance Standards for the Review and Guidance of Government Procurement of Imported Products” (2021 Edition) jointly issued by the Ministry of Finance and the Ministry of Industry and Information Technology leaked out. This notice clearly stipulates the proportion requirements for government agencies (institutions) to purchase domestic medical devices and instruments.
Among them, 137 types of medical devices are required to be 100% purchased domestically;
12 types of medical devices require 75% to be purchased domestically;
24 types of medical devices are required to be 50% purchased domestically;
Five types of medical devices require 25% to be purchased domestically.
In fact, in the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry” issued by the General Office of the State Council this year, it is clearly stated that if domestically produced drugs and medical devices can meet the requirements, government procurement projects must in principle purchase domestically produced products, and gradually improve the allocation level of domestically produced equipment in public medical institutions.
Immediately afterwards, the “Announcement of the State Administration of Taxation on the Revised and Issued “Administrative Measures for Value-Added Tax Refund for the Purchase of Domestic Equipment by R&D Institutions” pointed out that full VAT refunds for the purchase of domestic equipment by R&D institutions will continue.